Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home
Company Information for

NERRE THERAPEUTICS HOLDINGS LIMITED

Stevenage Bioscience Catalyst, Incubator Building, Gunnels Wood Road, Stevenage, HERTFORDSHIRE, SG1 2FX,
Company Registration Number
10753026
Private Limited Company
Active

Company Overview

About Nerre Therapeutics Holdings Ltd
NERRE THERAPEUTICS HOLDINGS LIMITED was founded on 2017-05-03 and has its registered office in Stevenage. The organisation's status is listed as "Active". Nerre Therapeutics Holdings Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
NERRE THERAPEUTICS HOLDINGS LIMITED
 
Legal Registered Office
Stevenage Bioscience Catalyst, Incubator Building
Gunnels Wood Road
Stevenage
HERTFORDSHIRE
SG1 2FX
 
Filing Information
Company Number 10753026
Company ID Number 10753026
Date formed 2017-05-03
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 2024-06-30
Account next due 2026-03-31
Latest return 2025-06-25
Return next due 2026-07-09
Type of accounts SMALL
VAT Number /Sales tax ID GB277385165  
Last Datalog update: 2025-07-01 15:49:11
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of NERRE THERAPEUTICS HOLDINGS LIMITED

Current Directors
Officer Role Date Appointed
IAIN DAVID DUKES
Director 2017-09-08
ANDREW KAY
Director 2017-09-15
MARY KERR
Director 2017-09-08
SAIYED KAASIM MAHMOOD
Director 2017-09-08
GEERT JAN MULDER
Director 2017-09-08
ENA PROSSER
Director 2017-09-08
Previous Officers
Officer Role Date Appointed Date Resigned
MICHAEL KEITH TROWER
Director 2017-05-03 2017-09-08

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
IAIN DAVID DUKES KANDY THERAPEUTICS LIMITED Director 2017-09-14 CURRENT 2017-05-03 Active
IAIN DAVID DUKES REVIRAL LIMITED Director 2016-12-22 CURRENT 2011-01-10 Active
IAIN DAVID DUKES NERRE THERAPEUTICS LTD Director 2016-12-22 CURRENT 2012-01-19 Active
ANDREW KAY NERRE THERAPEUTICS LTD Director 2017-09-15 CURRENT 2012-01-19 Active
MARY KERR KANDY THERAPEUTICS LIMITED Director 2017-09-14 CURRENT 2017-05-03 Active
MARY KERR NERRE THERAPEUTICS LTD Director 2015-10-01 CURRENT 2012-01-19 Active
MARY KERR CAUSEWAY LIFE SCIENCES CONSULTANTS LTD Director 2015-06-30 CURRENT 2015-06-30 Active
SAIYED KAASIM MAHMOOD KANDY THERAPEUTICS LIMITED Director 2017-09-14 CURRENT 2017-05-03 Active
SAIYED KAASIM MAHMOOD VENTUS MEDICAL LIMITED Director 2015-07-03 CURRENT 2014-12-22 Active
SAIYED KAASIM MAHMOOD NERRE THERAPEUTICS LTD Director 2013-03-12 CURRENT 2012-01-19 Active
GEERT JAN MULDER KANDY THERAPEUTICS LIMITED Director 2017-09-14 CURRENT 2017-05-03 Active
ENA PROSSER KANDY THERAPEUTICS LIMITED Director 2017-09-14 CURRENT 2017-05-03 Active
ENA PROSSER NERRE THERAPEUTICS LTD Director 2016-12-22 CURRENT 2012-01-19 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2025-07-01SMALL COMPANY ACCOUNTS MADE UP TO 30/06/24
2025-06-30CONFIRMATION STATEMENT MADE ON 25/06/25, WITH UPDATES
2024-06-25CONFIRMATION STATEMENT MADE ON 25/06/24, WITH UPDATES
2024-04-11Director's details changed for Mr Andrew Kay on 2024-04-09
2024-03-16SMALL COMPANY ACCOUNTS MADE UP TO 30/06/23
2023-09-1305/09/23 STATEMENT OF CAPITAL GBP 3630.8867
2023-09-11Cancellation of shares. Statement of capital on 2023-08-31 GBP 3,619.97775
2023-09-11Purchase of own shares
2023-06-26CONFIRMATION STATEMENT MADE ON 25/06/23, WITH NO UPDATES
2023-05-24Director's details changed for Mr Javier García Cogorro on 2021-06-25
2023-05-19Director's details changed for Mr Andrew Kay on 2023-03-01
2023-05-18Director's details changed for Dr Ena Prosser on 2019-04-15
2023-03-21SMALL COMPANY ACCOUNTS MADE UP TO 30/06/22
2022-07-0423/06/22 STATEMENT OF CAPITAL GBP 3623.3456
2022-07-04CONFIRMATION STATEMENT MADE ON 25/06/22, WITH UPDATES
2022-03-28AASMALL COMPANY ACCOUNTS MADE UP TO 30/06/21
2021-11-18SH0109/11/21 STATEMENT OF CAPITAL GBP 3603.8224
2021-11-18CS01CONFIRMATION STATEMENT MADE ON 25/06/21, WITH UPDATES
2021-08-26SH03Purchase of own shares
2021-08-06SH06Cancellation of shares. Statement of capital on 2021-06-25 GBP 1,813.002955
2021-07-26PSC08Notification of a person with significant control statement
2021-07-10RES09Resolution of authority to purchase a number of shares
2021-07-10MEM/ARTSARTICLES OF ASSOCIATION
2021-07-09SH0125/06/21 STATEMENT OF CAPITAL GBP 3413.387855
2021-07-07AASMALL COMPANY ACCOUNTS MADE UP TO 30/06/20
2021-06-30AP01DIRECTOR APPOINTED MR JAVIER GARCíA COGORRO
2021-06-30PSC07CESSATION OF ADVENT LIFE SCIENCES LLP AS A PERSON OF SIGNIFICANT CONTROL
2021-05-05CS01CONFIRMATION STATEMENT MADE ON 02/05/21, WITH NO UPDATES
2020-11-20MEM/ARTSARTICLES OF ASSOCIATION
2020-11-20RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution of adoption of Articles of Association
2020-05-04CS01CONFIRMATION STATEMENT MADE ON 02/05/20, WITH UPDATES
2020-03-18AAFULL ACCOUNTS MADE UP TO 30/06/19
2019-11-01SH10Particulars of variation of rights attached to shares
2019-11-01SH08Change of share class name or designation
2019-05-08CS01CONFIRMATION STATEMENT MADE ON 02/05/19, WITH UPDATES
2019-02-15SH0129/01/19 STATEMENT OF CAPITAL GBP 1813.2943
2019-02-05AAFULL ACCOUNTS MADE UP TO 30/06/18
2018-11-30RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution to purchase shares
  • Resolution of adoption of Articles of Association
2018-11-30SH0123/11/18 STATEMENT OF CAPITAL GBP 1806.92930
2018-11-30SH06Cancellation of shares. Statement of capital on 2018-11-23 GBP 1,806.93
2018-11-30SH03Purchase of own shares
2018-05-22CS01CONFIRMATION STATEMENT MADE ON 02/05/18, WITH UPDATES
2018-05-22PSC02Notification of Advent Life Sciences Llp as a person with significant control on 2017-09-08
2018-03-20LATEST SOC20/03/18 STATEMENT OF CAPITAL;GBP 1392.34955
2018-03-20SH0115/03/18 STATEMENT OF CAPITAL GBP 1392.34955
2018-01-24LATEST SOC24/01/18 STATEMENT OF CAPITAL;GBP 1392.22455
2018-01-24SH0122/01/18 STATEMENT OF CAPITAL GBP 1392.22455
2017-12-12RES01ADOPT ARTICLES 12/12/17
2017-11-16AP01DIRECTOR APPOINTED MR ANDREW KAY
2017-10-25SH02Sub-division of shares on 2017-09-08
2017-10-18AP01DIRECTOR APPOINTED DR IAIN DAVID DUKES
2017-10-17AP01DIRECTOR APPOINTED DR ENA PROSSER
2017-10-17AP01DIRECTOR APPOINTED DR GEERT JAN MULDER
2017-10-17AP01DIRECTOR APPOINTED DR SAIYED KAASIM MAHMOOD
2017-10-17PSC07CESSATION OF MICHAEL KEITH TROWER AS A PERSON OF SIGNIFICANT CONTROL
2017-10-17TM01APPOINTMENT TERMINATED, DIRECTOR MICHAEL KEITH TROWER
2017-10-17AP01DIRECTOR APPOINTED DR MARY KERR
2017-10-11SH0108/09/17 STATEMENT OF CAPITAL GBP 2728.8121
2017-10-11SH08Change of share class name or designation
2017-10-09MEM/ARTSARTICLES OF ASSOCIATION
2017-10-09RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2017-10-09RES0108/09/2017
2017-10-09RES12Resolution of varying share rights or name
2017-09-21SH08Change of share class name or designation
2017-09-20RES12VARYING SHARE RIGHTS AND NAMES
2017-09-20RES01ADOPT ARTICLES 14/09/2017
2017-09-14SH20STATEMENT BY DIRECTORS
2017-09-14LATEST SOC14/09/17 STATEMENT OF CAPITAL;GBP 1364.40605
2017-09-14SH1914/09/17 STATEMENT OF CAPITAL GBP 1364.40605
2017-09-14CAP-SSSOLVENCY STATEMENT DATED 14/09/17
2017-09-14RES13REDUCTION OF THE SHARE PREMIUM ACCOUNT 14/09/2017
2017-09-14RES06REDUCE ISSUED CAPITAL 14/09/2017
2017-08-08AA01CURREXT FROM 31/05/2018 TO 30/06/2018
2017-05-03LATEST SOC03/05/17 STATEMENT OF CAPITAL;GBP .0001
2017-05-03NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to NERRE THERAPEUTICS HOLDINGS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against NERRE THERAPEUTICS HOLDINGS LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
NERRE THERAPEUTICS HOLDINGS LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Intangible Assets
Patents
We have not found any records of NERRE THERAPEUTICS HOLDINGS LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for NERRE THERAPEUTICS HOLDINGS LIMITED
Trademarks
We have not found any records of NERRE THERAPEUTICS HOLDINGS LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for NERRE THERAPEUTICS HOLDINGS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as NERRE THERAPEUTICS HOLDINGS LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where NERRE THERAPEUTICS HOLDINGS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded NERRE THERAPEUTICS HOLDINGS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded NERRE THERAPEUTICS HOLDINGS LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.